(Reuters) – Johnson & Johnson said its experimental sirukumab treatment for rheumatoid arthritis showed mixed results against AbbVie Inc’s top-selling Humira in a large trial.
<img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=m6zri42uozY:EVVS_unt2iE:V_…To learn more visit: Reuters: Health News
The post J&J arthritis drug goes up against Humira, with mixed results appeared first on Online Medical Assistant Training Programs.
from WordPress https://onlinemedicalassistantprogramsedu.wordpress.com/2016/11/13/jj-arthritis-drug-goes-up-against-humira-with-mixed-results/
No comments:
Post a Comment